| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/02/2005 | EP1509233A1 Liquid formulation of decitabine and use of the same |
| 03/02/2005 | EP1509220A1 A pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4- 2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro 2,5]octan-6-one |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1296650B1 Methods and compositions for treating pain of the mucous membrane |
| 03/02/2005 | EP1244649B1 Cyclic amp-specific phosphodiesterase inhibitors |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | EP1014976B1 Novel substituted imidazole compounds |
| 03/02/2005 | EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | CN1589279A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589254A Double esters |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1589144A Use of an ascomycin for the treatment of blepharitis |
| 03/02/2005 | CN1589141A Medicament for the treatment of viral skin and tumour diseases |
| 03/02/2005 | CN1589136A Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 03/02/2005 | CN1589103A Nestin-expressing hair follicle stem cells |
| 03/02/2005 | CN1586576A Spots removing paste |
| 03/02/2005 | CN1586567A Medicine for treating comedo and acne on face |
| 03/02/2005 | CN1586557A Hair growing water for stopping hair loss and scurf |
| 03/02/2005 | CN1586544A Medicinal wine and its producing method |
| 03/02/2005 | CN1586521A Healing agent for skin wound surface |
| 03/02/2005 | CN1586520A Chinese medicine paste for mainly treating malignant sore |
| 03/02/2005 | CN1586505A Oral administration liquid for clearing tinea |
| 03/02/2005 | CN1586501A Use of ground beetle in preparing medicine for treating virus infection disease |
| 03/02/2005 | CN1586486A Cefpodoxime proxetil soft capsule preparation and its preparing method |
| 03/02/2005 | CN1191266C Compositions for treating inflammatory response |
| 03/02/2005 | CN1191243C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 03/02/2005 | CN1191233C N-substituted nitrogen heterocyclic compound |
| 03/02/2005 | CN1191085C Ointment for treating burns, scalds and knife wound |
| 03/02/2005 | CN1191081C Psoriasis-treating ointment and its compounding process |
| 03/02/2005 | CN1191078C External use ointment for treating burn and scald |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 03/02/2005 | CN1191059C Foaming emulsion for treating fatty skin |
| 03/02/2005 | CN1191055C Cosmetic and/or pharmaceutical preparations |
| 03/01/2005 | US6861435 3-(amino-imino-methyl)benzyl derivatives with an amide -n-sulfonylamido on the methyl of the benzyl |
| 03/01/2005 | US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 03/01/2005 | US6861078 Plant extracts with anti-radical type action |
| 03/01/2005 | US6861077 Use of plant extracts in a cosmetic composition to protect keratinous fibers |
| 03/01/2005 | US6861067 Hydrogel wound dressing and the method of making and using the same |
| 02/24/2005 | WO2005016928A1 Imidazopyridine derivatives |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016907A1 Novel flavone derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 02/24/2005 | WO2005016514A2 Combinatorial synthesis on support |
| 02/24/2005 | WO2005016382A1 Antibodies to c-met |
| 02/24/2005 | WO2005016353A1 Topical ointment for vesicating chemical warfare agents |
| 02/24/2005 | WO2005016350A1 Ammonium salts of ornithine derivatives for treating inflammatory diseases |
| 02/24/2005 | WO2005016336A1 Method and composition for treating burned skin |
| 02/24/2005 | WO2004103353A3 Topical treatment of sebum related skin conditions |
| 02/24/2005 | WO2004096862B1 Improved extration and purification method for cereal beta (1-3) beta (1-4) glucan |
| 02/24/2005 | WO2004093907A3 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents |
| 02/24/2005 | WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 02/24/2005 | WO2004082668A8 Coenzyme q10-containing proliposome and preparation thereof |
| 02/24/2005 | WO2003061362A3 Methods and compositions for treating polycystic ovary syndrome |
| 02/24/2005 | WO2002074237A8 Compositions and methods for the therapy and diagnosis of kidney cancer |
| 02/24/2005 | US20050043544 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/24/2005 | US20050043516 TACI antibodies and uses thereof |
| 02/24/2005 | US20050043398 such as 2-ethoxycarbonyl-7-hydroxychromone, for the care, preservation or improvement of the general state of the skin or hair |
| 02/24/2005 | US20050043393 Antilipemic agents |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043346 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/24/2005 | US20050043340 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 02/24/2005 | US20050043336 Quinazoline derivatives as antitumor agents |
| 02/24/2005 | US20050043335 Heterocyclic derivatives of glycinamide and their medical use |
| 02/24/2005 | US20050043333 Quinazolinone derivative |
| 02/24/2005 | US20050043330 Antiinflammation agents |
| 02/24/2005 | US20050043328 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043286 Use of an ascomycin for the treatment of blepharitis |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050043222 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042652 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics |
| 02/24/2005 | US20050042347 Plant extracts; extraction of oils; skin disorders; antiulcer agents; antiallergens |
| 02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/24/2005 | US20050042299 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 02/24/2005 | US20050042265 Composition for cutaneous repair and cicatrization comprising exclusively a true physical hydrogel of chitosan |
| 02/24/2005 | US20050042243 Oat extracts: refining, compositions and methods of use |
| 02/24/2005 | US20050042215 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound |
| 02/24/2005 | US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents |
| 02/24/2005 | US20050042188 A 4-hydroxy-L-proline alkyl ester; sunscreen agents |
| 02/24/2005 | CA2536146A1 Splice variants of erbb ligands, compositions and uses thereof |
| 02/24/2005 | CA2535620A1 6-substituted anilino purines as rtk inhibitors |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535416A1 Imidazopyridine derivatives |
| 02/24/2005 | CA2534563A1 Antibodies to c-met |
| 02/24/2005 | CA2530604A1 Combinatorial synthesis on support |
| 02/24/2005 | CA2524921A1 Method and composition for treating burned skin |
| 02/23/2005 | EP1508570A1 Novel physiolgically active substances |
| 02/23/2005 | EP1508327A1 Use of chromen-4-one derivatives for the care of skin and hair |
| 02/23/2005 | EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling |